Novo Nordisk ADR (NVO) has a current stock price of $99.53. During the previous trading session, the stock witnessed a notable rise, reaching a high of $99.625 after opening at $98.96. The stock’s low for the day was $98.11, and it eventually closed at $96.43.
Novo Nordisk ADR’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $104.00 on 10/13/23, and the lowest price during that time was $55.98, recorded on 11/17/22.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
52-week price history of NVO Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Novo Nordisk ADR’s current trading price is -4.30% away from its 52-week high, while its distance from the 52-week low is 77.80%. The stock’s price range for this period has remained between $55.98 and $104.00. The Healthcare sector company’s shares managed to surpass a trading volume of around 4.94 million for the day, which was noticeably higher compared to the shares’ average daily volume of 4.58 million over the last three months.
Financial Performance and Market Capitalization
Novo Nordisk ADR (NVO) has experienced a quarterly rise of 8.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 335.91B and boasts a workforce of 54393 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 90.93, with a change in price of +21.54. Similarly, Novo Nordisk ADR recorded 4,147,605 in trading volume during the last 100 days, posting a change of +27.62%.
NVO Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for NVO stands at 0.29. Similarly, the long-term debt-to-equity ratio is also 0.21.
NVO Stock Stochastic Average
As of today, the raw stochastic average of Novo Nordisk ADR over the past 50 days is 73.77%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 63.92%. Additionally, the Stochastic %K and %D values for the company were 52.83% and 60.65%, respectively, over the past 20 days.
NVO Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price gain of 47.08% this year. Over the last six months, there has been a weaker performance of 18.10%. The price of NVO leaped by -1.03% during the last 30 days period. For the last 5-days stocks have slided -0.50%.
